Human cord blood progenitors sustain thymic T-cell development and a novel form of angiogenesis

Area of Science:

• Hematology
• Immunology
• Stem Cell Biology

Background:

• Human umbilical cord blood (CB) is a promising source for allogeneic bone marrow transplantation (BMT), especially in pediatric cases.
• CB contains hematopoietic progenitors for erythroid, myeloid, and B-cell lineages.
• The capacity of CB cells to reconstitute T-cell development and thymopoiesis post-BMT remains largely unexplored.

Purpose of the Study:

• To investigate whether engrafted CB cells can generate T-cell progenitors that reconstitute thymopoiesis.
• To determine if CB stem cells can support T-cell development in a human thymus graft within an in vivo model.
• To explore potential non-hematopoietic functions of CB stem cells in transplantation.

Main Methods:

• Engraftment of human CB progenitors into the bone marrow (BM) of immunodeficient mice.
• Co-transplantation with a human thymic graft to assess T-cell development.
• Analysis of circulating T-cell progenitors and their homing to the thymus.
• Evaluation of endothelial cell lineage contribution and angiogenesis in the graft.

Main Results:

• Engrafted CB progenitors sustained human thymopoiesis by generating T-cell progenitors.
• These T-cell progenitors successfully homed to and developed within the human thymic graft.
• CB stem cells also differentiated into endothelial cells, contributing to graft revascularization and wound healing.
• Demonstrated a novel role for CB-derived stem cells in angiogenesis.

Conclusions:

• Human CB stem cell transplantation can effectively reconstitute thymic-dependent T-cell lymphopoiesis.
• CB stem cells possess a previously unrecognized capacity to contribute to angiogenesis.
• These findings highlight the broad therapeutic potential of CB stem cells beyond hematopoietic reconstitution.